1. Home
  2. GRND vs AMPH Comparison

GRND vs AMPH Comparison

Compare GRND & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grindr Inc.

GRND

Grindr Inc.

HOLD

Current Price

$13.59

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

BUY

Current Price

$25.51

Market Cap

1.0B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
GRND
AMPH
Founded
2009
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
1.0B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
GRND
AMPH
Price
$13.59
$25.51
Analyst Decision
Buy
Hold
Analyst Count
5
7
Target Price
$20.80
★ $22.50
AVG Volume (30 Days)
★ 1.4M
449.1K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 158.11
N/A
EPS
0.24
★ 0.81
Revenue
$439,898,000.00
★ $719,887,000.00
Revenue This Year
$23.35
$3.87
Revenue Next Year
$17.14
$4.90
P/E Ratio
$59.04
★ $31.30
Revenue Growth
★ 27.64
N/A
52 Week Low
$9.79
$16.65
52 Week High
$18.50
$29.52

Technical Indicators

Market Signals
Indicator
GRND
AMPH
Relative Strength Index (RSI) 32.04 60.43
Support Level $12.86 $18.51
Resistance Level $16.20 $29.40
Average True Range (ATR) 0.69 1.00
MACD -0.17 -0.01
Stochastic Oscillator 12.15 48.51

Price Performance

Historical Comparison
GRND
AMPH

About GRND Grindr Inc.

Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discrete and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: